These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2955539)

  • 21. Identification of a putative thromboxane A2/prostaglandin H2 receptor in human platelet membranes.
    Saussy DL; Mais DE; Burch RM; Halushka PV
    J Biol Chem; 1986 Mar; 261(7):3025-9. PubMed ID: 3005276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species.
    Narumiya S; Okuma M; Ushikubi F
    Br J Pharmacol; 1986 Jun; 88(2):323-31. PubMed ID: 3730697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second messenger function of phosphatidic acid in platelet activation.
    Kroll MH; Zavoico GB; Schafer AI
    J Cell Physiol; 1989 Jun; 139(3):558-64. PubMed ID: 2738101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic analysis of a TxA2 receptor antagonist. Evidence for the existence of an uptake system.
    Modesti PA; Abbate R; Gensini GF; Colella A; Serneri GG
    Eicosanoids; 1990; 3(3):139-43. PubMed ID: 2146970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular activation by thromboxane A2 and other eicosanoids.
    Reilly M; Fitzgerald GA
    Eur Heart J; 1993 Dec; 14 Suppl K():88-93. PubMed ID: 8131796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of platelet shape change, inositol metabolism, and Ca mobilization in patients with platelet dysfunction].
    Fuse I; Hattori A; Higuchi W
    Rinsho Byori; 1992 Mar; 40(3):287-96. PubMed ID: 1518180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue- and species-specific differences in ligand binding to thromboxane A2 receptors.
    Dorn GW
    Am J Physiol; 1991 Jul; 261(1 Pt 2):R145-53. PubMed ID: 1830459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet aggregation, storage pool deficiency, and protein phosphorylation in mice with Chediak-Higashi syndrome.
    Pratt HL; Carroll RC; Jones JB; Lothrop CD
    Am J Vet Res; 1991 Jun; 52(6):945-50. PubMed ID: 1652907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Platelet thromboxane A2 receptor].
    Ushikubi F; Hirata M; Narumiya S; Okuma M
    Nihon Rinsho; 1992 Feb; 50(2):264-8. PubMed ID: 1535387
    [No Abstract]   [Full Text] [Related]  

  • 32. Binding of an [125I] labelled thromboxane A2/prostaglandin H2 receptor agonist to baboon platelets.
    Dorn GW; De Jesus A
    Prostaglandins; 1989 Dec; 38(6):645-53. PubMed ID: 2534431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photoaffinity labelling and isoelectric focusing of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor.
    Mais DE; Halushka PV
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():168-71. PubMed ID: 2526465
    [No Abstract]   [Full Text] [Related]  

  • 34. Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity.
    Hirakata H; Ushikubi F; Toda H; Nakamura K; Sai S; Urabe N; Hatano Y; Narumiya S; Mori K
    Anesthesiology; 1996 Dec; 85(6):1447-53. PubMed ID: 8968193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in platelet sensitivity to thromboxane A2 in pediatric patients with nephrotic syndrome].
    Watanabe M; Suzuki J; Suzuki H
    Nihon Jinzo Gakkai Shi; 1996 Aug; 38(8):356-63. PubMed ID: 8828355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subnormal platelet response to thromboxane A2 in a patient with chronic myeloid leukaemia.
    Okuma M; Takayama H; Uchino H
    Br J Haematol; 1982 Jul; 51(3):469-77. PubMed ID: 6809032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pH dependency of the binding of [3H]BAY U 3405 and various non-labelled ligands to the thromboxane A2/prostaglandin H2 receptor of human platelet membranes.
    Theis JG; Dellweg H; Perzborn E; Gross R
    Eur J Pharmacol; 1992 Jun; 226(2):149-56. PubMed ID: 1386320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor.
    Mais DE; Halushka PV
    Prog Clin Biol Res; 1989; 301():303-7. PubMed ID: 2529550
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of inhaled anesthetics on the platelet aggregation and the ligand-binding affinity of the platelet thromboxane A2 receptor.
    Hirakata H; Ushikubi F; Narumiya S; Hatano Y; Nakamura K; Mori K
    Anesth Analg; 1995 Jul; 81(1):114-8. PubMed ID: 7598237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of thromboxane A2 receptor with lipid rafts is a determinant for platelet functional responses.
    Moscardó A; Vallés J; Latorre A; Santos MT
    FEBS Lett; 2014 Aug; 588(17):3154-9. PubMed ID: 24996187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.